[1] Univ Paris-Sud,Hopital de Bicetre, Service de Neurologie and Centre de Reference des Neuropathies Amyloides Familiales (NNERF), INSERM U1195
[2] APHP,Commercial
[3] Alnylam Pharmaceuticals,Unidade Clinica de Paramiloidose
[4] Hospital de Santo Antonio,undefined